Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Less-toxic combination of immune-based drug and chemotherapy drug produce long-term remissions in CLL

Less-toxic combination of immune-based drug and chemotherapy drug produce long-term remissions in CLL

Stemline licenses clinically active oncology vaccine for dual targeting of tumor bulk and cancer stem cells

Stemline licenses clinically active oncology vaccine for dual targeting of tumor bulk and cancer stem cells

Harvard Medical School selects Agilent's NMR spectrometer for biomolecular research applications

Harvard Medical School selects Agilent's NMR spectrometer for biomolecular research applications

EpiCept 2010 fourth quarter net loss is $0.06 per share

EpiCept 2010 fourth quarter net loss is $0.06 per share

FDA grants Fast Track designation to Sunesis' vosaroxin for treatment of AML

FDA grants Fast Track designation to Sunesis' vosaroxin for treatment of AML

MD Anderson physician honored for impact on blood, marrow transplantation

MD Anderson physician honored for impact on blood, marrow transplantation

Knocking out genes completely and exclusively in Natural Killer cells

Knocking out genes completely and exclusively in Natural Killer cells

Cerasome filled molecular-sized bubbles to target liver cancer cells

Cerasome filled molecular-sized bubbles to target liver cancer cells

Cancer-causing retrovirus prolongs survival of host cells

Cancer-causing retrovirus prolongs survival of host cells

Study: Antibody-directed chemotherapy may be effective for majority of younger AML sufferers

Study: Antibody-directed chemotherapy may be effective for majority of younger AML sufferers

Gilead Sciences signs definitive agreement to acquire Calistoga for $375 million

Gilead Sciences signs definitive agreement to acquire Calistoga for $375 million

Positive preliminary data from Fate Therapeutics FT1050 Phase 1b trial in patients with life-threatening conditions

Positive preliminary data from Fate Therapeutics FT1050 Phase 1b trial in patients with life-threatening conditions

Advancell announces positive results from Acadra clinical study in Chronic Lymphocytic Leukemia

Advancell announces positive results from Acadra clinical study in Chronic Lymphocytic Leukemia

International study shows reprogramming cells lead to genomic aberrations

International study shows reprogramming cells lead to genomic aberrations

Biocare, HJF sign license agreement to distribute antibody against prostate cancer

Biocare, HJF sign license agreement to distribute antibody against prostate cancer

Researchers identify CD19-L protein that facilitates recognition, destruction of leukemia cells

Researchers identify CD19-L protein that facilitates recognition, destruction of leukemia cells

Frequent, potentially avoidable readmissions are major driver of pediatric health care costs

Frequent, potentially avoidable readmissions are major driver of pediatric health care costs

Cyclacel's CYC065 CDK inhibitor demonstrates potential against breast cancer resistant to trastuzumab

Cyclacel's CYC065 CDK inhibitor demonstrates potential against breast cancer resistant to trastuzumab

TI Pharma launches new research project on stem cell transplant

TI Pharma launches new research project on stem cell transplant

Loyola offers stem cell transplants to older patients with leukemia and lymphoma

Loyola offers stem cell transplants to older patients with leukemia and lymphoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.